StonvexLoading…
StonvexStonvexStonvexCore line items from M's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2026 2026-01-31 | Q4 2025 2025-11-01 | Q3 2025 2025-08-02 | Q2 2025 2025-05-03 |
|---|---|---|---|---|
Revenue | $21.76B | $14.13B | $9.41B | $4.60B |
Operating Income | $1.03B | $285.00M | $242.00M | $94.00M |
Net Income | $642.00M | $135.00M | $87.00M | $38.00M |
EPS (Diluted) | $2.32 | $0.48 | $0.44 | $0.13 |
Total Assets | $16.24B | $17.06B | $15.55B | $16.09B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $1.25B | $447.00M | $829.00M | $932.00M |
Free Cash Flow OCF − CapEx | $1.06B | $-25.00M | $76.00M | $-164.00M |
Shares Outstanding | 263.00M | 277.10M | 278.30M | 280.70M |